Stockscreener 앱 받기
0.8716
3.28%
-0.0296
전일 마감가:
$0.9012
열려 있는:
$0.8905
하루 거래량:
1.19M
Relative Volume:
0.87
시가총액:
$166.28M
수익:
$4.71M
순이익/손실:
$-58.01M
주가수익비율:
-1.0585
EPS:
-0.8234
순현금흐름:
$-46.68M
1주 성능:
-3.97%
1개월 성능:
-18.54%
6개월 성능:
-26.76%
1년 성능:
-10.93%
1일 변동 폭
$0.8605
$0.9035
1주일 범위
$0.8605
$0.9396
52주 변동 폭
$0.8605
$1.6293
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
0.8716 | 172.34M | 4.71M | -58.01M | -46.68M | -0.8234 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
LUCD|Lucid Diagnostics Inc|Price:0.904|Chg%:-0.003 - TradingKey
Lucid Diagnostics Inc (LUCD) Institutional Confidence - TradingKey
Lucid Diagnostics Inc (LUCD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lucid Diagnostics Inc (LUCD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lucid Diagnostics Inc (LUCD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lucid Diagnostics Inc (LUCD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lucid Diagnostics Market Sentiment - Benzinga España
Lucid Diagnostics Inc (LUCD) Cash Flow - TradingKey
Lucid Diagnostics Inc (LUCD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LUCD|Lucid Diagnostics Inc|Price:0.908|Chg%:-0.038 - TradingKey
AAPL: Apple Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Lucid Diagnostics (LUCD) Drops 6.4% to $0.95 – Testing Key SupportAnalyst Upgrade Stocks - dars.gov.et
Lucid Diagnostics (LUCD) Nears One-Dollar Threshold After Modest DeclineArms Index - dars.gov.et
LUCD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Lucid Diagnostics (LUCD) Holds Steady Near Support: Can the Modest Uptick Signal a Reversal?Volume Breadth - dars.gov.et
LUCD Q1 2026 Earnings: Significant EPS Miss and No Reported Revenue Raise ConcernsTech Earnings Analysis - dars.gov.et
Lucid Diagnostics (LUCD) Extends Decline: Approaching Key Support at $0.99 After 3.7% DropKeltner Channel - dars.gov.et
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - GuruFocus
LUCD Q1 2026 Earnings: Significant Earnings Miss as Company Reports No RevenueEstimate Accuracy - DonanımHaber
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
Lucid Diagnostics (LUCD) Edges Higher as Diagnostics Sector Sees Renewed InterestStop Loss Guidance - dars.gov.et
Lucid Diagnostics: Positioned For A Medicare-Driven Inflection (NASDAQ:LUCD) - Seeking Alpha
LUCD News | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill
Lucid Diagnostics Inc.(NasdaqCM:LUCD) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 3000 Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 2500 Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 2000 Value Benchmark - marketscreener.com
Lucid Diagnostics Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Pre-Revenue Challenges - dars.gov.et
Lucid Diagnostics Inc.(NasdaqCM:LUCD) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Lucid Diagnostics Inc. Actuals & Estimates (NASDAQ:LUCD) - TradingView
LUCD Forecast — Price Target — Prediction for 2027 - TradingView
Lucid Diagnostics Shareholders Approve Stock Authorization Increase - TipRanks
Lucid Diagnostics (LUCD) boosts authorized shares to 400M and re-elects directors - Stock Titan
LUCD: All proposals passed, including director elections and share authorization increase - TradingView
Transcript : Lucid Diagnostics Inc.Shareholder/Analyst Call - marketscreener.com
Lucid Diagnostics (LUCD) Holds Steady at $1.03: Stock Consolidates Near Key LevelsPre-Earnings Momentum - dars.gov.et
LUCD Q1 2026 Earnings: Wider-Than-Expected Loss Drives Stock Despite No RevenueSubscription Growth Report - dars.gov.et
Top Lucid Diagnostics (LUCD) Competitors 2026 - MarketBeat
Lucid Diagnostics Inc (LUCD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Diagnostics Inc (LUCD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lucid Diagnostics Inc (LUCD) Valuation: PE, PB & Fair Value Analysis - TradingKey
LUCD Q1 2026 Earnings: Deep EPS Miss Masks Operational Progress; Stock Edges HigherQuarterly Earnings - DonanımHaber
Lucid Diagnostics (LUCD) Edges Higher, Testing Key Resistance at $1.05Risk Reward Setups - dars.gov.et
LUCD Q1 2026 Earnings: EPS Misses Estimates by 100.7% as Company Reports No RevenueEarnings Turnaround - dars.gov.et
Certain Stock Options of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Ending on 9-JUN-2026. - marketscreener.com
Lucid Diagnostics misses on revenue, but 2026 growth outlook lights up bull case - MSN
Lucid Diagnostics Misses On Revenue, But 2026 Growth Outlook Lights Up Bull Case - Benzinga
LUCD Maintained by Ascendiant Capital -- Price Target Raised to $9.25 - GuruFocus
LUCD Q1 2026 Earnings: Significant EPS Miss Amid Pre-Revenue Development StageEBITDA Estimate Trend - dars.gov.et
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results - Yahoo Finance
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lucid Diagnostics Inc 주식 (LUCD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
Aug 20 '25 |
Buy |
1.02 |
100,000 |
101,840 |
665,443 |
1.04%
11.95%
자본화:
|
볼륨(24시간):